Shaping a Path to Discovery
Takeda focuses on a variety of therapeutic areas including cardiovascular/metabolic, central nervous system, immunology and respiratory, and oncology.
Learn more about Takeda products and review the associated complete prescribing information.
As a research-based pharmaceutical company, efforts are currently focused on pre-clinical work and clinical development activities in the Americas. Takeda Development Center Americas, Inc. works closely with Takeda’s research, development and commercialization entities worldwide to transform discoveries into innovative medicines that improve lives. Through close strategic relationships with the entire Takeda family of companies, Takeda Development Center Americas, Inc. collaborates in the earliest stages of a compound’s development to ensure effective product lifecycle management and continued focus on patient needs. Our team of scientists, physicians and development experts is continually exploring new opportunities to address unmet therapeutic needs, including new treatment approaches, strategic collaborations and partnerships to expand our product pipeline.
The Takeda family of companies works in tandem to explore new areas of medicine and strives toward better health for patients worldwide through leading innovation in medicine.
In collaboration with our global partners, we adhere to Good Clinical Practices (GCP), federal requirements, and international guidelines in conducting clinical trials to protect the rights and welfare of our study participants and the validity of the study data. We have adopted the Pharmaceutical Research and Manufacturers of America (PhRMA) code of integrity, compliance, and social responsibility. We also follow Current Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP).
Please view our full pipeline here.